Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoqinglong granules plus Seretide for mild persistent asthma
ChiCTR-TRC-10001072Phase 4Completed
- Sponsor
- China National Center for Biotechnology Development
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Seretide + Xiaoqinglong granules with Seretide + placebo (2 arms). Primary endpoint: Asthma control. Started Mar 2010; status: completed.
02
Drugs
so-cheong-ryong-tang
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-10001072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001072.